Ziraoui, N.-E.; Salazar, M.; Kensington, A. BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation With Supporting Clinical and Pharmacological Evidence. IJPHMR 2026, 6 (4), 36-44. https://doi.org/10.62051/ijphmr.v6n4.06.